ADVANCED / METASTATIC SOLID TUMOR

Clinical trials for ADVANCED / METASTATIC SOLID TUMOR explained in plain language.

Never miss a new study

Get alerted when new ADVANCED / METASTATIC SOLID TUMOR trials appear

Sign up with your email to follow new studies for ADVANCED / METASTATIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Terminated 1

New cancer drug targets notorious KRAS mutation in first human trial

Disease control Not yet recruiting

This is an early-stage study to test the safety and initial effects of a new drug called ABO2102 in adults with advanced solid tumors that have a specific genetic change called a KRAS mutation. The main goals are to find a safe dose and see how the body handles the drug, while al…

Matched conditions: ADVANCED / METASTATIC SOLID TUMOR

Phase: PHASE1 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

ADVANCED / METASTATIC SOLID TUMOR

Get alerted when new ADVANCED / METASTATIC SOLID TUMOR trials appear

New cancer drug targets notorious KRAS mutation in first human trial